CW February 2010
Volume 19Issue Number 2 February 2010 ISSN 1059380 Consolidation with Lenalidomide After Autologous Transplantation for Myeloma Leads to Anti-Tumor EffectConsolidation with lenalidomide alone after autologous transplantation for myeloma is feasible and can decrease residual tumor mass and lead to an
anti-tumor effect.
Sources and Additional Reading: Michel Attal of Hospital Purpan, Toulouse, France, at the American Society of Hematology annual meeting Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2010Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
